Abiopharma

TechCreate Group Ltd. and pQCee Intend to Collaborate on One of the First Quantum-Safe QR Hybrid POS Terminal

USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth Leader

Equinor ASA: Notice of annual general meeting 12 May 2026

QXO Announces Investor Presentation Regarding Acquisition of TopBuild

Ennis, Inc. Reports Results for the Quarter and Year Ended February 28, 2026, Sets Record Date for Annual Shareholder Meeting

Equinor ASA: Innkalling til ordinær generalforsamling 12. mai 2026

Cleveland-Cliffs Reports First-Quarter 2026 Results

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting

Dole plc Schedules First Quarter 2026 Financial Results Release

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026